India’s single-specialty health provider market is projected to grow to $12.3 billion by 2030, a significant increase from around $4.4 billion in 2025. This growth represents a 22% compound annual growth rate, outpacing the broader provider sector. Bessemer Venture Partners highlighted that specialty health care offers attractive financial profiles with short payback periods and sustainable EBITDA margins exceeding 20%.
The report emphasized a shift in India’s healthcare provider market, moving away from capital-intensive, multi-specialty “mega-hospitals” towards purpose-built centers. While multi-specialty hospitals are crucial for complex care, there is a rising ecosystem of focused providers focusing on repeatable protocols, concentrated clinical expertise, and asset-light expansion models. These specialty-native platforms prioritize clinical focus, leading to improved outcomes and higher patient satisfaction in specific care segments.
Specialty segments’ founders have the opportunity to establish dominance in the absence of nationally recognized brands in the industry. The report suggested that emerging leaders in these segments could become appealing IPO candidates or acquisition targets for established healthcare conglomerates. Nithin Kaimal, Partner at Bessemer Venture Partners, India, noted that the next generation of iconic Indian healthcare companies will likely evolve one specialty at a time, emphasizing the importance of combining deep clinical expertise with scalability to create lasting value.
Investment activity in India’s healthcare sector has been significant, with the country accounting for 26% of Asia-Pacific healthcare private equity deal volume in 2024. The focus has primarily been on provider and related services, as well as biopharma and related services.
